Maxbax in India: bigger-penis and erection claims checked

The Maxbax sales page for India promises a bigger penis, “massive, everlasting erections,” five times longer before ejaculation and twice as long and hard erections. It also says clinical trials support the product. But the page links no trial, shows no complete formula with ingredient amounts, and lists ingredients that do not match the CPA.TL offer description. The page does not give a buyer enough evidence to trust those promises.

“Bigger,” “5x longer,” and “no more dysfunctions”: claims without a cited trial

The landing page uses all of these claims: “increased penis size,” “no more dysfunctions,” “expands penile chambers,” “5x ejaculation time,” and “2x longer & harder erections.” It says Maxbax is backed by extensive research and clinical trials, but names no study, researchers, journal, registry number, participant group, dose, duration, or measured outcome. The 5x and 2x figures have no stated starting point or method. A sentence saying “clinical trials” is not a way for a reader to verify a clinical trial.

The product description and the sales page name different ingredients

CPA.TL describes Maxbax as a blend of shilajit, gokshur, ashwagandha, krounchbeej and safed musli. The India landing page’s ingredient section instead names aloe vera, maca and tongkat ali. It does not show a complete ingredient label or the amount of each ingredient per capsule. These pages may be describing different versions, or one may be out of date; neither page explains the difference. Until the seller identifies the exact pack and publishes its full label, a buyer cannot tell which formula is being offered.

A pill cannot substantiate a penis-size promise by repeating it

Mayo Clinic says advertised penis-enlargement pills and lotions have not been proved to work; it also says there is no guaranteed safe, proven way to enlarge the penis. That directly conflicts with Maxbax’s promises of increased size and expanded penile chambers. This is not a laboratory finding about Maxbax: it is the available medical evidence on enlargement products, and the sales page provides no product-specific evidence that would change it.

Repeated erection problems need a health check, not a sales script

The NHS advises seeing a doctor if erection problems keep happening. Causes can include diabetes, high blood pressure, high cholesterol, medicines, anxiety, depression or hormone problems, and treatment depends on the cause. The U.S. National Center for Complementary and Integrative Health says there is no definite evidence that herbal products are safe and effective for erectile dysfunction. It also warns that some sexual-enhancement supplements have contained undeclared drug ingredients that can interact dangerously with prescriptions. That category-wide warning is not evidence that Maxbax contains a hidden drug; this product has not been tested here.

The discount and urgency are not consistent on the page

The form shows a price of ₹2,490 beside a crossed-out ₹4,980, but labels the offer “33% discount.” The displayed prices make the reduction 50%, not 33%. The page also says only five units remain, uses a countdown timer, claims a 4.9/5 rating from 1,500 customers without naming a review service or explaining how the rating was collected, and asks for a name and phone number so an operator can call. These details do not prove fraud, but they are reasons to slow down and request the full price, exact quantity, written cancellation terms and a verifiable seller identity before sharing a number or agreeing to an order.

Who is responsible for the order in India?

The landing-page footer names Galaxy Trade LTD and gives a London address and a Gmail contact. It does not clearly identify an India-based manufacturer, importer or seller on the page we reviewed. FSSAI publishes specific rules for health supplements and food advertising; among other things, claims attributed directly to a product need scientific substantiation, and food claims generally cannot promise treatment or cure of disease unless specifically permitted. We have not established Maxbax’s regulatory classification or whether a particular authorization exists, so this review does not declare the product illegal. Ask the seller for the exact Indian business and licence details and verify them with the relevant authority.

Ask these questions before paying or confirming a call

• Can you send a photo of every side of the exact Maxbax pack that will be shipped to India, including its manufacturer, importer, full ingredients and per-capsule amounts?
• What is the FSSAI category and licence number for this exact product, and who is the responsible Indian business?
• Where can I read the registered or published human trial of this exact formula that measured the advertised erection, ejaculation-time and penis-size results?
• Is ₹2,490 the final price for one pack? Are there shipping charges, repeat orders, extra packs or other conditions?
• What are the written cancellation, refund and privacy terms before I provide my phone number?

Our verdict: do not order Maxbax on the strength of this page

The ad makes dramatic promises about penis size, erections and ejaculation time but supplies no linked product trial or measurable basis for its 5x and 2x figures. Its two public descriptions do not even agree on the ingredients, and the displayed price math contradicts the discount label. That is enough for us not to recommend a purchase from this page. The seller can change that assessment by publishing the exact pack label, verifiable product-specific human evidence, clear Indian seller and licence details, and complete order terms. We have not bought or tested Maxbax and are not claiming that an authority has found it fake or unlawful.

If erection problems keep recurring, speak with a qualified doctor or urologist. Do not stop prescribed medicine or take an unverified sexual-enhancement supplement in place of an assessment. If a seller pressures you to decide during a call, end the call and ask for the product, total price and terms in writing.

Reviewed on 27 October 2026. We checked the public CPA.TL offer and the English India sales page, then compared its claims with public guidance from Mayo Clinic, the NHS, NCCIH and FSSAI. We did not purchase the product, inspect a delivered package, test it in a laboratory or verify a Maxbax licence or trial that the seller did not link.